Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Adjusting your budget monthly helps you stay aligned with your financial goals. Explore the benefits of this practice for better control.
23,559 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Lawmakers edge toward final action on the ROAD Act, a bill that could reshape how lenders price risk and how quickly ...
A former NASDAQ chief warns that SpaceX’s unprecedented lockup could unlock roughly $800 billion in stock by October,...
Paradigm closes a $1.2 billion fourth fund to back crypto platforms while expanding its reach into AI and robotics, s...
Oil rises and stock indexes slip as tensions in the Strait of Hormuz intensify. Investors watch the ships dark clock ...
Two retirees with identical $1.5 million portfolios may see thousands more in annual costs simply because they live i...
Britain designated the IRGC on July 17, expanding criminal exposure for crypto firms that handle or retain value link...
The ethereum staking address holds about half of ETH in circulation, a milestone that highlights how staking and burn...
GLPI's Q4 2025 results show growth, margin trends, and clearer guidance for 2026. This analysis translates the number...
Uber's top executive forecasts a future where autonomous taxis handle the bulk of trips within two decades, a scenari...
First Trust AIRR, a small-cap industrial-focused ETF, has surged in 2026 and boasts a five-year performance well ahea...
A veteran diplomat weighs the odds of regime change in Iran as U.S.-led strikes escalate, warning that history in the...